1-3 of 3
maribavir
Close
Sort by
Journal Articles

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

Drew J. Winston, Jo-Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, Estil Vance, George J. Alangaden, Roy F. Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Stephen A. Villano, Michael Boeckh
Journal: Blood
Blood (2008) 111 (11): 5403–5410.
https://doi.org/10.1182/blood-2007-11-121558
Published: 2008
Journal Articles

Pharmacokinetics of Oral Maribavir, a Novel Anti-Cytomegalovirus Agent, in Subjects with Renal Impairment.

Suzanne Swan, William Smith, Thomas Marbury, Mary Schumacher, Carolyn Dougherty, Bruce Mico, Stephen Villano
Journal: Blood
Blood (2006) 108 (11): 2863.
https://doi.org/10.1182/blood.V108.11.2863.2863
Published: 2006
Journal Articles

Prophylaxis Against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

Drew Winston, Jo-Anne van Burik, Vinod Pullarkat, Genovefa Papanicolaou, Ravi Vij, Estil Vance, George Alangaden, Roy Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Carolyn Dougherty, Stephen Villano, Michael Boeckh
Journal: Blood
Blood (2006) 108 (11): 593.
https://doi.org/10.1182/blood.V108.11.593.593
Published: 2006